Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
19.04
+0.38 (2.04%)
May 30, 2025, 4:08 PM HKT

HKG:2190 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Revenue
782.48527.75334.09177.9127.63
Upgrade
Revenue Growth (YoY)
48.27%57.97%87.78%543.88%461.95%
Upgrade
Cost of Revenue
222.58142.7781.4246.0311.34
Upgrade
Gross Profit
559.9384.99252.67131.8816.29
Upgrade
Selling, General & Admin
265.76277.92249.47195.8751.45
Upgrade
Research & Development
233.23261.01233.46168.172.07
Upgrade
Other Operating Expenses
-10.06-6.8-6.78-13.94-9.88
Upgrade
Operating Expenses
488.96532.15476.18350.05113.63
Upgrade
Operating Income
70.93-147.16-223.51-218.17-97.34
Upgrade
Interest Expense
---0.72-0.31-0.67
Upgrade
Interest & Investment Income
65.1777.7995.5713.090.36
Upgrade
Earnings From Equity Investments
-1.1----
Upgrade
Currency Exchange Gain (Loss)
1.51-0.2619.63-8.28-4.47
Upgrade
EBT Excluding Unusual Items
136.51-69.63-109.04-213.66-102.12
Upgrade
Gain (Loss) on Sale of Investments
-36.21-8.514.8113.951.62
Upgrade
Gain (Loss) on Sale of Assets
-0.05-0.59-9.320.020.03
Upgrade
Pretax Income
100.26-78.73-113.56-199.69-100.47
Upgrade
Net Income
100.26-78.73-113.56-199.69-100.47
Upgrade
Net Income to Common
100.26-78.73-113.56-199.69-100.47
Upgrade
Shares Outstanding (Basic)
323329330295195
Upgrade
Shares Outstanding (Diluted)
328329330295195
Upgrade
Shares Change (YoY)
-0.22%-0.51%12.15%51.26%9.59%
Upgrade
EPS (Basic)
0.31-0.24-0.34-0.68-0.52
Upgrade
EPS (Diluted)
0.31-0.24-0.34-0.68-0.52
Upgrade
Free Cash Flow
-17.26-92.48-226.06-194.32-127.47
Upgrade
Free Cash Flow Per Share
-0.05-0.28-0.68-0.66-0.65
Upgrade
Gross Margin
71.55%72.95%75.63%74.13%58.95%
Upgrade
Operating Margin
9.06%-27.88%-66.90%-122.63%-352.29%
Upgrade
Profit Margin
12.81%-14.92%-33.99%-112.24%-363.61%
Upgrade
Free Cash Flow Margin
-2.21%-17.52%-67.66%-109.22%-461.34%
Upgrade
EBITDA
103.6-118.05-203.47-208.49-90.72
Upgrade
EBITDA Margin
13.24%-22.37%-60.90%-117.18%-
Upgrade
D&A For EBITDA
32.6729.1120.049.686.62
Upgrade
EBIT
70.93-147.16-223.51-218.17-97.34
Upgrade
EBIT Margin
9.06%-27.88%-66.90%-122.63%-
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.